Literature DB >> 24469078

Glaucoma management in Boston keratoprosthesis type I recipients.

Pho Nguyen1, Vikas Chopra.   

Abstract

PURPOSE OF REVIEW: To review the literature on management of glaucoma in Boston keratoprosthesis type I recipients. RECENT
FINDINGS: Glaucoma is a prevalent and important cause of permanent loss of sight in Boston keratoprosthesis recipients. The management of glaucoma is challenging as there are no reliable and accurate means to monitor the intraocular pressure (IOP) in these patients, and no standardized protocols exist regarding management. Because a significant number of patients require glaucoma drainage device placement, further studies are needed to determine ways to reduce the risk of shunt-associated complications. Surgical adjustments including posterior shunt placement, adjunctive corneal patch graft, and selection of a different size bandage contact lens can help reduce shunt-associated complications. Anterior segment optical coherence tomography is useful in elucidating the mechanisms of failure to control IOP. Continual innovations in imaging and IOP measurement technologies will assist surgeons' preoperative planning and postoperative management.
SUMMARY: In keratoprosthesis recipients, glaucoma often leads to permanent loss of sight. It is imperative that these patients be monitored with vigilance by a multidisciplinary team to prevent progression. Pooled data from multiple centers and technologic innovations will assist the surgeon to design a surgical approach and postoperative management regimen for the individual recipient.

Entities:  

Mesh:

Year:  2014        PMID: 24469078     DOI: 10.1097/ICU.0000000000000035

Source DB:  PubMed          Journal:  Curr Opin Ophthalmol        ISSN: 1040-8738            Impact factor:   3.761


  8 in total

1.  Successful acute and late management of a chemical burn with primary implantation of Boston type 1 keratoprosthesis.

Authors:  Abhishek Ranjan; Sirisha Senthil; Virender Sangwan
Journal:  BMJ Case Rep       Date:  2015-08-26

2.  Innovative approaches to glaucoma management of Boston keratoprosthesis type 1.

Authors:  Thasarat S Vajaranant; Jessica Liu; Jacob Wilensky; M Soledad Cortina; Ahmad A Aref
Journal:  Curr Ophthalmol Rep       Date:  2016-07-26

3.  Endoscopic Cyclophotocoagulation for the Treatment of Glaucoma in Boston Keratoprosthesis Type II Patient.

Authors:  Linda Yi-Chieh Poon; James Chodosh; Demetrios G Vavvas; Claes H Dohlman; Teresa C Chen
Journal:  J Glaucoma       Date:  2017-04       Impact factor: 2.503

4.  Long-term outcomes of the aphakic snap-on Boston type I keratoprosthesis at the Bascom Palmer Eye Institute.

Authors:  Allister Gibbons; Ella H Leung; Luis J Haddock; Carlos A Medina; Viviana Fernandez; Jean-Marie A Parel; Heather A Durkee; Guillermo Amescua; Eduardo C Alfonso; Victor L Perez
Journal:  Clin Ophthalmol       Date:  2018-02-15

5.  Resolution of an exposed pars plana Baerveldt shunt in a patient with a Boston keratoprosthesis type 1 without surgery.

Authors:  Daniel J Oh; Raman Michael; Thasarat Vajaranant; M Soledad Cortina; Ellen Shorter
Journal:  Ther Adv Ophthalmol       Date:  2019-08-12

Review 6.  Boston Type 1 Keratoprosthesis: Updated Perspectives.

Authors:  Manachai Nonpassopon; Muanploy Niparugs; Maria Soledad Cortina
Journal:  Clin Ophthalmol       Date:  2020-04-29

7.  Timing of glaucoma treatment in patients with MICOF: A retrospective clinical study.

Authors:  Zhao Li; Qun Wang; Shi-Feng Zhang; Yi-Fei Huang; Li-Qiang Wang
Journal:  Front Med (Lausanne)       Date:  2022-09-29

8.  CorNeat KPro: Ocular Implantation Study in Rabbits.

Authors:  Gilad Litvin; Ido Klein; Yoav Litvin; Guy Klaiman; Abraham Nyska
Journal:  Cornea       Date:  2021-09-01       Impact factor: 3.152

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.